HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jian-Qi Lian Selected Research

Hantaan virus nucleocapsid protein

7/2009Analysis of the immune response to Hantaan virus nucleocapsid protein C-terminal-specific CD8(+) T cells in patients with hemorrhagic fever with renal syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jian-Qi Lian Research Topics

Disease

16Infections
01/2022 - 10/2008
8Chronic Hepatitis B
01/2017 - 10/2009
3Inflammation (Inflammations)
01/2021 - 11/2011
2Disease Progression
01/2022 - 06/2014
2COVID-19
01/2021 - 12/2020
2Virus Diseases (Viral Diseases)
12/2020 - 05/2003
2Hepatitis B
01/2015 - 06/2014
1HIV Infections (HIV Infection)
01/2022
1Opportunistic Infections (Opportunistic Infection)
01/2022
1Neoplasms (Cancer)
01/2022
1Bone Resorption
01/2021
1Periodontitis
01/2021
1Pneumonia (Pneumonitis)
01/2021
1Hemorrhagic Fever with Renal Syndrome (HFRS)
07/2009
1Gram-Positive Bacterial Infections
02/2006
1Hepatocellular Carcinoma (Hepatoma)
03/2004
1Poliomyelitis (Polio)
05/2003

Drug/Important Bio-Agent (IBA)

5AntigensIBA
01/2021 - 07/2009
4CytokinesIBA
01/2021 - 11/2011
2ChemokinesIBA
01/2021 - 06/2014
2InterleukinsIBA
01/2021 - 11/2014
2Proteins (Proteins, Gene)FDA Link
12/2020 - 07/2009
2Pharmaceutical PreparationsIBA
12/2020 - 02/2006
2Interleukin-22 (IL-22)IBA
01/2016 - 11/2011
2Toll-Like Receptor 2IBA
01/2015 - 02/2010
2VaccinesIBA
11/2014 - 05/2003
2TelbivudineFDA Link
07/2013 - 02/2012
2Toll-Like Receptors (Toll-Like Receptor)IBA
10/2009 - 10/2008
2MicroRNAs (MicroRNA)IBA
03/2004 - 05/2003
2antibiotic G 418IBA
03/2004 - 05/2003
1AntibodiesIBA
01/2022
1Nucleic AcidsIBA
01/2022
1meplazumabIBA
01/2021
1Monoclonal AntibodiesIBA
01/2021
1Immunoglobulin G (IgG)IBA
01/2021
1Interleukin-18 (Interleukin 18)IBA
01/2021
1Matrix Metalloproteinases (MMPs)IBA
01/2021
1Interleukin-18 ReceptorsIBA
01/2021
1Angiotensin-Converting Enzyme 2IBA
12/2020
1InterferonsIBA
01/2017
1MucinsIBA
01/2017
1Antiviral Agents (Antivirals)IBA
01/2017
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2016
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2016
1Messenger RNA (mRNA)IBA
01/2016
1Interleukin-17 (Interleukin 17)IBA
01/2015
1interleukin-21 (interleukin 21)IBA
11/2014
1DNA (Deoxyribonucleic Acid)IBA
11/2014
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
06/2014
1adefovirIBA
07/2013
1B7-H1 AntigenIBA
02/2012
1Nucleocapsid ProteinsIBA
07/2009
1Viral ProteinsIBA
07/2009
1Immunodominant EpitopesIBA
07/2009
1Peptides (Polypeptides)IBA
07/2009
1Hantaan virus nucleocapsid proteinIBA
07/2009
1Interferon-gamma (Interferon, gamma)IBA
03/2009
1Claudin-1IBA
03/2009
1Scavenger Receptors (Scavenger Receptor)IBA
03/2009
1LipopolysaccharidesIBA
10/2008
1Interleukin-6 (Interleukin 6)IBA
10/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2008
1Anti-Bacterial Agents (Antibiotics)IBA
02/2006
1VancomycinFDA LinkGeneric
02/2006
15' Untranslated Regions (5' UTR)IBA
03/2004
1LipofectamineIBA
03/2004
1RNA (Ribonucleic Acid)IBA
05/2003
1NeomycinFDA LinkGeneric
05/2003
1Internal Ribosome Entry SitesIBA
05/2003

Therapy/Procedure

5Therapeutics
01/2022 - 11/2011
1Immunotherapy
01/2021
1Blood Transfusion (Blood Transfusions)
12/2008